Clinical trial
SOLMANIA - Comparison of Valproate-Amisulpride and Valproate-Haloperidol in…
NCT00126009 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00126009 |
|---|---|
| Title | SOLMANIA - Comparison of Valproate-Amisulpride and Valproate-Haloperidol in Bipolar I Patients |
| Official title | A 3-Month, Open, Randomised Trial Comparing the Efficacy and Safety of the Association Valproate-Amisulpride to the Association Valproate-Haloperidol in Bipolar I Patients Suffering From a Manic Episode |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Bipolar Disorder |
| Intervention type | Drug |
| Interventions | Amisulpride |
| Enrollment | 120 |
| Start date | May 1, 2004 |
| First posted | Aug 2, 2005 |
| Last update posted | Apr 10, 2008 |
| Countries | Czechia, France, Poland, Slovakia, Spain |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: